Holocene Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Holocene Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,880	Closed	-$611K	–	866
2023 Q3	$611K	Sell	10,880 -69,420	-86%	-$3.91M	﹤0.01%	660
2023 Q2	$4.05M	Buy	80,300 +7,473	+10%	+$398K	0.02%	397
2023 Q1	$3.97M	Buy	+72,827	New	+$4.25M	0.02%	325

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Holocene Advisors's AXNX Position: Q4 2023 in Review

Holocene Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 10,880 shares — an estimated $611K sold.

Holocene Advisors first reported a position in AXNX in Q1 2023 and held it in 3 quarters. The position peaked at $4.05M in Q2 2023. 229 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

Holocene Advisors reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Holocene Advisors sold 10,880 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $611K.
Holocene Advisors first reported a position in Axonics, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Holocene Advisors's Axonics, Inc. Common Stock position peaked at $4.05M in Q2 2023.
229 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on Holocene Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.